je.st
news
Home
› Teva's Generic Version of Xeloda Gains FDA Approval For Metastatic Colorectal And Breast Cancers
Teva's Generic Version of Xeloda Gains FDA Approval For Metastatic Colorectal And Breast Cancers
2013-09-17 08:07:34| Biotech - Topix.net
The FDA granted approval to a generic version of Xeloda, produced by Teva Pharmaceutical, for the treatment of metastatic colorectal and breast cancers.
Tags: version
approval
generic
gains
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||